The global paroxetine hydrochloride market is expected to rise at a considerable CAGR during the forecast period (2022-2028). Paroxetine is a drug that is used to treat social mental problems, serious depression, anxiety disorders, panic attacks, and, among other things. the increasing prevalence of mental health disorders and the rising awareness about mental health among people is the major factor driving the market growth. As per WHO, depression is a common illness worldwide, with an estimated 3.8% of the population affected, including 5.0% among adults and 5.7% among adults older than 60 years. 

The global hemodialysis blood tubing sets market is anticipated to grow at a significant CAGR during the forecast period. The primary factor contributing to the growth of the market is the rising geriatric population across the globe coupled with the rising incidences of various chronic diseases such as cancer, kidney failure, arthritis, and others. Hemodialysis is a treatment used to filter wastes and water from the blood. This treatment supports to control of blood pressure while balancing minerals such as potassium, sodium, and calcium in the blood. People aged above 50 years usually suffer from the problems such as blood pressure and mineral imbalance.

The global 3 phosphoinositide dependent protein kinase 1 market is anticipated to grow at a significant CAGR during the forecast period. Rise in inclination towards the adoption of various strategic initiative such as product expansion, mergers and acquisitions, partnerships, collaborations, and geographical expansion is the major factor contributing to the growth of the market. For instance, in September 2020, Gilead Sciences, Inc. and Immunomedics entered into a definitive agreement pursuant to which Gilead acquired Immunomedics for $88 per share in cash. 

The global indoleamine 2,3 dioxygenase 1 market is anticipated to grow at a substantial CAGR during the forecast period. Immunotherapy's recent application in clinical oncology has changed the way we treat advanced human tumors. Immunotherapeutic drugs targeting the CTLA4 and PD-1/PD-L1 axis are currently available to treat a range of malignancies. However, to further improve patient outcomes with these medications, a unique treatment approach is required. indoleamine 2,3-dioxygenase 1 (IDO1) is a rate-limiting enzyme in the peripheral tissue metabolism of the essential amino acid tryptophan. 

The global high mobility group protein B1 market is expected to grow at a significant CAGR during the forecast period (2022-2028). The rising prevalence of cancer such as leukemia and multiple myeloma, globally is a major factor driving market growth. As per the Leukemia & Lymphoma Society (LLS), total of 186,400 people in the US were diagnosed with leukemia, lymphoma or myeloma in 2021. 

The global cyclin dependent kinase (CDK) inhibitors market is anticipated to grow at a considerable CAGR during the forecast period. CDKs are nutrient metabolic enzymes that regulate the cell cycle. CDK binds to cyclin, forming a complex that works together. In the human body, there are approximately 20 members of the CDK family. Further, an inhibitor is any compound or chemical that inhibits the function of CDKs. Cancer cells proliferate excessively, and (CDK) inhibitors are used as a treatment to regulate this mechanism.

The global ertapenem market is anticipated to grow at a considerable CAGR during the forecast period (2022-2028). Ertapenem is also prescribed for patients undergoing certain types of surgery that poses a risk of infection. Incidence of various bacterial diseases is increasing rapidly that is accelerating the demand for ertapenem drug. Pneumonia acquired in hospital settings due to longer patient stays, is often difficult to treat and exists as the comorbidity to various chronic diseases such as cancer, organ transplant. etc. It also interferes with the disease treatment and may be fatal if not treated with broad-spectrum antibiotics such as carbapenem-based antibiotics. 

The global medicinal fungi market is anticipated to grow at a considerable CAGR of 9.6% during the forecast period (2022-2028). Medicinal fungi are mushrooms that are grown for their high antioxidant, protein, amino acid, and vitamin content. Medicinal fungi are well-known for their ability to treat the common cold, seasonal allergies, asthma and bronchitis, inflammations, and to improve nervous system function. Globally, as consumer interest in health food products grows, particularly in Europe and North America, distributors are expanding the number of outlets that offer a diverse range of functional beverages infused with medicinal fungi. 

The nitric oxide synthase brain market is anticipated to grow at a considerable CAGR during the forecast period (2022-2028). The market growth is driven by the presence of prominent players that are contributing to the market growth. All the major players in the nitric oxide synthase brain market are involved in strategic alliances like acquisitions, partnerships, new product approvals, and collaborations to launch new products to stay competitive in the market. For instance, in January 2022, Eli Lilly and Company Entos Pharmaceuticals' Fusogenix nucleic acid delivery technology to research, develop and commercialize nucleic acid products targeting the central and peripheral nervous system.

The global tyrosine kinase inhibitor market is expected to rise at a considerable CAGR during the forecast period (2022-2028). The prominent factors such as rise in incidences of various cancers other chronic diseases globally, development in healthcare facilities, and high adoption of digital healthcare technology are driving the growth of the global tyrosine kinase inhibitor market. Apart from these, the companies operating in the tyrosine kinase inhibitors industry are focusing on increasing their geographic presence by means of strategic acquisitions and collaborations with leading players & increasing FDA approvals of therapeutic drugs in their respective domains and geographies along with strong investment in R&D activities.